| Implications of the hybrid epithelial/mesenchymal phenotype in metastasis MK Jolly, M Boareto, B Huang, D Jia, M Lu, JN Onuchic, H Levine, ... Frontiers in Oncology 5, 155, 2015 | 771 | 2015 |
| MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination M Lu, MK Jolly, H Levine, JN Onuchic, E Ben-Jacob Proceedings of the National Academy of Sciences 110 (45), 18144-18149, 2013 | 539 | 2013 |
| Tumor budding: the name is EMT. Partial EMT. AD Grigore, MK Jolly, D Jia, MC Farach-Carson, H Levine Journal of clinical medicine 5 (5), 51, 2016 | 534 | 2016 |
| EMT and MET: necessary or permissive for metastasis? MK Jolly, KE Ware, S Gilja, JA Somarelli, H Levine Molecular Oncology, 2017 | 425 | 2017 |
| Stability of the hybrid epithelial/mesenchymal phenotype MK Jolly, SC Tripathi, D Jia, SM Mooney, M Celiktas, SM Hanash, ... Oncotarget 7 (19), 27067-27084, 2016 | 416 | 2016 |
| Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas MK Jolly, JA Somarelli, M Sheth, A Biddle, SC Tripathi, AJ Armstrong, ... Pharmacology & therapeutics 194, 161-184, 2019 | 287 | 2019 |
| Toward understanding cancer stem cell heterogeneity in the tumor microenvironment F Bocci, L Gearhart-Serna, M Boareto, M Ribeiro, E Ben-Jacob, GR Devi, ... Proceedings of the National Academy of Sciences 116 (1), 148-157, 2019 | 283 | 2019 |
| Epithelial–mesenchymal transition, a spectrum of states: role in lung development, homeostasis, and disease MK Jolly, C Ward, MS Eapen, S Myers, O Hallgren, H Levine, SS Sohal Developmental dynamics 247 (3), 346-358, 2018 | 236 | 2018 |
| Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric JT George, MK Jolly, S Xu, JA Somarelli, H Levine Cancer research 77 (22), 6415-6428, 2017 | 221 | 2017 |
| Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome SC Tripathi, HL Peters, A Taguchi, H Katayama, H Wang, A Momin, ... Proceedings of the National Academy of Sciences 113 (11), E1555-E1564, 2016 | 195 | 2016 |
| Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing AP Deshmukh, SV Vasaikar, K Tomczak, S Tripathi, P Den Hollander, ... Proceedings of the National Academy of Sciences 118 (19), e2102050118, 2021 | 193 | 2021 |
| Acute vs. chronic vs. cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression K Saxena, MK Jolly Biomolecules 9 (8), 339, 2019 | 191 | 2019 |
| Towards elucidating the connection between epithelial–mesenchymal transitions and stemness MK Jolly, B Huang, M Lu, SA Mani, H Levine, E Ben-Jacob Journal of The Royal Society Interface 11 (101), 20140962, 2014 | 187 | 2014 |
| Coupling the modules of EMT and stemness: A tunable 'stemness window' model. MK Jolly, D Jia, M Boareto, SA Mani, KJ Pienta, E Ben-Jacob, H Levine Oncotarget 6 (28), 25161-25174, 2015 | 175 | 2015 |
| Hypoxia, partial EMT and collective migration: emerging culprits in metastasis K Saxena, MK Jolly, K Balamurugan Translational Oncology 13 (11), 100845, 2020 | 173 | 2020 |
| Jagged–Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype M Boareto, MK Jolly, M Lu, JN Onuchic, C Clementi, E Ben-Jacob Proceedings of the National Academy of Sciences 112 (5), E402-E409, 2015 | 170 | 2015 |
| Hybrid epithelial/mesenchymal phenotype (s): The ‘fittest’for metastasis? MK Jolly, SA Mani, H Levine Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870 (2), 151-157, 2018 | 156 | 2018 |
| Cancer stem cell plasticity–a deadly deal AP Thankamony, K Saxena, R Murali, MK Jolly, R Nair Frontiers in molecular biosciences 7, 79, 2020 | 150 | 2020 |
| Phenotypic plasticity, bet-hedging, and androgen independence in prostate cancer: role of non-genetic heterogeneity MK Jolly, P Kulkarni, K Weninger, J Orban, H Levine Frontiers in oncology 8, 50, 2018 | 141 | 2018 |
| Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2 N Ashary, A Bhide, P Chakraborty, S Colaco, A Mishra, K Chhabria, ... Frontiers in cell and developmental biology 8, 783, 2020 | 139 | 2020 |
Herbert LevineProfessor of Physics, Northeastern UniversityVerified email at northeastern.edu
